Zevra Therapeutics, Inc. (ZVRA) Earnings History
Profitable14 years of earnings data (2012–2025) · Positive TTM net income
Loading earnings history...
Zevra Therapeutics, Inc. (ZVRA) Earnings Overview
As of June 28, 2026, Zevra Therapeutics, Inc. (ZVRA) reported trailing twelve-month net income of $124M, reflecting +159.2% year-over-year growth. The company earned $2.06 per diluted share over the past four quarters, with a net profit margin of 78.2%.
Looking at the long-term picture, ZVRA's historical earnings data spans multiple years. The company achieved its highest annual net income of $83M in fiscal 2025, representing a new all-time high.
Zevra Therapeutics, Inc. maintains industry-leading profitability with a gross margin of 84.5%, operating margin of -4.0%, and net margin of 78.2%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including RARE (-$609M net income, -85.4% margin), FOLD (-$27M net income, -4.3% margin), ACAD ($376M net income, 36.5% margin), ZVRA has outperformed on profitability metrics. Compare ZVRA vs RARE →
ZVRA Earnings vs Peers
Earnings metrics vs comparable public companies
ZVRA Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $83M | +178.9% | -$4M | $1.35 | 78.2% | -4.0% |
| 2024 | -$106M | -129.1% | -$87M | $-2.28 | -446.9% | -368.5% |
| 2023 | -$46M | -72.0% | -$50M | $-1.30 | -167.7% | -180.6% |
| 2022 | -$27M | -212.9% | -$43M | $-0.78 | -263.5% | -418.9% |
| 2021 | -$9M | +33.0% | $8M | $-2.11 | -29.9% | 27.0% |
| 2020 | -$13M | +48.0% | -$6M | $-3.21 | -96.0% | -42.2% |
| 2019 | -$25M | +56.6% | -$20M | $-13.23 | -191.0% | -158.4% |
| 2018 | -$56M | -30.1% | -$56M | $-50.39 | - | - |
| 2017 | -$43M | -162.7% | -$33M | $-47.37 | - | - |
| 2016 | -$17M | +69.8% | -$37M | $-18.10 | - | - |
| 2015 | -$55M | -123.5% | -$23M | $-118.69 | - | - |
| 2014 | -$24M | -367.9% | -$16M | $-31.79 | - | - |
| 2013 | -$5M | -7321.6% | -$5M | $-10.69 | - | - |
| 2012 | $-70,416 | - | -$5M | $-0.47 | - | - |
Download Data
Export ZVRA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ZVRA — Frequently Asked Questions
Quick answers to the most common questions about buying ZVRA stock.
What is ZVRA earnings per share (EPS)?
ZVRA trailing twelve-month (TTM) diluted EPS is $2.06, reflecting +159.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Zevra Therapeutics, Inc.'s net income?
Zevra Therapeutics, Inc. (ZVRA) trailing twelve-month net income is $124M as of 2025. Earnings grew +159.2% year-over-year.
Is ZVRA profitable?
Yes, ZVRA is profitable with a TTM net income of $124M and a net profit margin of +78.2%.
What is ZVRA's earnings growth rate?
ZVRA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are ZVRA's profit margins?
Zevra Therapeutics, Inc. net profit margin is +78.2%, operating margin is -4.0%, and gross margin is +84.5%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +85.7%.
Is ZVRA growing earnings?
Yes, ZVRA earnings are accelerating — EPS growth of +159.2% exceeds the 5-year CAGR of N/A. TTM net income reached $124M. Earnings momentum is strengthening.
What was ZVRA's best earnings year?
Zevra Therapeutics, Inc.'s highest annual net income on record is $83M, achieved in fiscal year 2025. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were ZVRA's earnings last quarter?
ZVRA's most recent reported quarter was Q1 2026. Net income was $38M with diluted EPS of $0.60. For a full breakdown of all quarters, see the quarterly earnings table on this page.